Defining consensus opinion to develop randomised controlled trials in rare diseases using Bayesian design: An example of a proposed trial of adalimumab versus pamidronate for children with CNO/CRMO
利用贝叶斯设计制定罕见病随机对照试验的共识意见：以阿达木单抗与帕米膦酸钠治疗儿童慢性非梗阻性骨髓炎（CNO/CRMO）的拟议试验为例。
期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0215739
Ramanan, A V; Hampson, L V; Lythgoe, H; Jones, A P; Hardwick, B; Hind, H; Jacobs, B; Vasileiou, D; Wadsworth, I; Ambrose, N; Davidson, J; Ferguson, P J; Herlin, T; Kavirayani, A; Killeen, O G; Compeyrot-Lacassagne, S; Laxer, R M; Roderick, M; Swart, J F; Hedrich, C M; Beresford, M W
